Takeda Pharmaceutical Co (JP:4502) has released an update.
Takeda Pharmaceutical Co. has released its audited consolidated financial statements for the fiscal years ending March 31, 2023, and 2024, in accordance with International Financial Reporting Standards. The report covers the company’s performance and includes financial details represented in American Depositary Shares and Receipts. All amounts are rounded to the nearest digit for ease of interpretation.
For further insights into JP:4502 stock, check out TipRanks’ Stock Analysis page.